CYBB and neurodegenerative disease: In patients with neurodegenerative diseases such as Alzheimer’s and Amyotrophic Lateral Sclerosis, increased serum levels of NADPH oxidase 2 (NOX2) and elevated plasma levels of LPS from intestinal Gram-negative bacteria have been observed [151].